CA1237075A - Blood component storage container and method utilizing a polyvinyl chloride plastic formulation free or essentially free of leachable materials - Google Patents
Blood component storage container and method utilizing a polyvinyl chloride plastic formulation free or essentially free of leachable materialsInfo
- Publication number
- CA1237075A CA1237075A CA000434933A CA434933A CA1237075A CA 1237075 A CA1237075 A CA 1237075A CA 000434933 A CA000434933 A CA 000434933A CA 434933 A CA434933 A CA 434933A CA 1237075 A CA1237075 A CA 1237075A
- Authority
- CA
- Canada
- Prior art keywords
- polyvinyl chloride
- parts
- blood
- resin
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 239000004800 polyvinyl chloride Substances 0.000 title claims abstract description 45
- 229920000915 polyvinyl chloride Polymers 0.000 title claims abstract description 44
- 239000000463 material Substances 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 26
- 239000012503 blood component Substances 0.000 title claims abstract description 20
- 239000004033 plastic Substances 0.000 title claims abstract description 16
- 229920003023 plastic Polymers 0.000 title claims abstract description 15
- 239000012633 leachable Substances 0.000 title claims abstract description 8
- 238000003860 storage Methods 0.000 title abstract description 45
- 238000009472 formulation Methods 0.000 title abstract description 32
- 239000004014 plasticizer Substances 0.000 claims abstract description 32
- 210000002381 plasma Anatomy 0.000 claims abstract description 25
- 239000012760 heat stabilizer Substances 0.000 claims abstract description 16
- 150000003839 salts Chemical class 0.000 claims abstract description 13
- 235000003441 saturated fatty acids Nutrition 0.000 claims abstract description 8
- 150000004671 saturated fatty acids Chemical class 0.000 claims abstract description 8
- 229920012485 Plasticized Polyvinyl chloride Polymers 0.000 claims abstract description 7
- 210000004369 blood Anatomy 0.000 claims description 51
- 239000008280 blood Substances 0.000 claims description 51
- 239000000306 component Substances 0.000 claims description 27
- 239000011347 resin Substances 0.000 claims description 27
- 229920005989 resin Polymers 0.000 claims description 27
- KRADHMIOFJQKEZ-UHFFFAOYSA-N Tri-2-ethylhexyl trimellitate Chemical compound CCCCC(CC)COC(=O)C1=CC=C(C(=O)OCC(CC)CCCC)C(C(=O)OCC(CC)CCCC)=C1 KRADHMIOFJQKEZ-UHFFFAOYSA-N 0.000 claims description 21
- 230000006641 stabilisation Effects 0.000 claims description 18
- 238000011105 stabilization Methods 0.000 claims description 18
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 13
- 239000008116 calcium stearate Substances 0.000 claims description 13
- 235000013539 calcium stearate Nutrition 0.000 claims description 13
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 10
- 239000011575 calcium Substances 0.000 claims description 9
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 4
- 239000000194 fatty acid Substances 0.000 abstract description 4
- 229930195729 fatty acid Natural products 0.000 abstract description 4
- 150000004665 fatty acids Chemical class 0.000 abstract description 4
- 238000007567 mass-production technique Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 15
- 239000003634 thrombocyte concentrate Substances 0.000 description 14
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 238000012545 processing Methods 0.000 description 8
- 239000011701 zinc Substances 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 210000004623 platelet-rich plasma Anatomy 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 235000015112 vegetable and seed oil Nutrition 0.000 description 7
- 239000008158 vegetable oil Substances 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical group [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000004803 Di-2ethylhexylphthalate Substances 0.000 description 5
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical group CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 238000002386 leaching Methods 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000000386 microscopy Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 125000005591 trimellitate group Chemical group 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000006161 blood agar Substances 0.000 description 2
- 239000003114 blood coagulation factor Substances 0.000 description 2
- 238000003490 calendering Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 150000002194 fatty esters Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- YEVQZPWSVWZAOB-UHFFFAOYSA-N 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(I)C(CBr)=C1 YEVQZPWSVWZAOB-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 101100243025 Arabidopsis thaliana PCO2 gene Proteins 0.000 description 1
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Chemical class CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 1
- ZVFDTKUVRCTHQE-UHFFFAOYSA-N Diisodecyl phthalate Chemical compound CC(C)CCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC(C)C ZVFDTKUVRCTHQE-UHFFFAOYSA-N 0.000 description 1
- NEHDRDVHPTWWFG-UHFFFAOYSA-N Dioctyl hexanedioate Chemical class CCCCCCCCOC(=O)CCCCC(=O)OCCCCCCCC NEHDRDVHPTWWFG-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000490229 Eucephalus Species 0.000 description 1
- 229920006385 Geon Polymers 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 239000004930 VINNOL Substances 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- IAONKHJEAQWGBJ-UHFFFAOYSA-N bis(8-methylnonyl) hydrogen phosphate Chemical compound CC(C)CCCCCCCOP(O)(=O)OCCCCCCCC(C)C IAONKHJEAQWGBJ-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- HRBZRZSCMANEHQ-UHFFFAOYSA-L calcium;hexadecanoate Chemical compound [Ca+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O HRBZRZSCMANEHQ-UHFFFAOYSA-L 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005264 electron capture Effects 0.000 description 1
- -1 ethylhexyl Chemical group 0.000 description 1
- 229960000301 factor viii Drugs 0.000 description 1
- 230000012953 feeding on blood of other organism Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229960004838 phosphoric acid Drugs 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 108010058237 plasma protein fraction Proteins 0.000 description 1
- 229940081857 plasma protein fraction Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- GSURLQOINUQIIH-UHFFFAOYSA-N triheptyl phosphate Chemical compound CCCCCCCOP(=O)(OCCCCCCC)OCCCCCCC GSURLQOINUQIIH-UHFFFAOYSA-N 0.000 description 1
- MXHBQKVKHGQWRB-UHFFFAOYSA-N trihexyl benzene-1,2,4-tricarboxylate Chemical compound CCCCCCOC(=O)C1=CC=C(C(=O)OCCCCCC)C(C(=O)OCCCCCC)=C1 MXHBQKVKHGQWRB-UHFFFAOYSA-N 0.000 description 1
- SFENPMLASUEABX-UHFFFAOYSA-N trihexyl phosphate Chemical compound CCCCCCOP(=O)(OCCCCCC)OCCCCCC SFENPMLASUEABX-UHFFFAOYSA-N 0.000 description 1
- JNXDCMUUZNIWPQ-UHFFFAOYSA-N trioctyl benzene-1,2,4-tricarboxylate Chemical compound CCCCCCCCOC(=O)C1=CC=C(C(=O)OCCCCCCCC)C(C(=O)OCCCCCCCC)=C1 JNXDCMUUZNIWPQ-UHFFFAOYSA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940012185 zinc palmitate Drugs 0.000 description 1
- GJAPSKMAVXDBIU-UHFFFAOYSA-L zinc;hexadecanoate Chemical compound [Zn+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O GJAPSKMAVXDBIU-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/143—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/141—Plasticizers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/10—Esters; Ether-esters
- C08K5/12—Esters; Ether-esters of cyclic polycarboxylic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/24—Medical-surgical bags
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Liquid Crystal (AREA)
- External Artificial Organs (AREA)
- Materials For Medical Uses (AREA)
- Liquid Crystal Display Device Control (AREA)
- Transforming Electric Information Into Light Information (AREA)
- Control Of Indicators Other Than Cathode Ray Tubes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US424,679 | 1982-09-27 | ||
| US06/424,679 US4505708A (en) | 1982-09-27 | 1982-09-27 | Blood component storage container and method utilizing a polyvinyl chloride plastic formulation free or essentially free of leachable materials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1237075A true CA1237075A (en) | 1988-05-24 |
Family
ID=23683486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000434933A Expired CA1237075A (en) | 1982-09-27 | 1983-08-19 | Blood component storage container and method utilizing a polyvinyl chloride plastic formulation free or essentially free of leachable materials |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4505708A (enExample) |
| EP (1) | EP0120873B1 (enExample) |
| JP (1) | JPS59501612A (enExample) |
| AU (1) | AU573181B2 (enExample) |
| CA (1) | CA1237075A (enExample) |
| DE (1) | DE3381486D1 (enExample) |
| WO (1) | WO1984001286A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD284035S (en) | 1983-05-23 | 1986-05-27 | Union Carbide Corporation | Chemical container |
| AU569544B2 (en) * | 1983-10-14 | 1988-02-04 | Pall Corporation | Citrate-ester plasticized pvc blood containers |
| JP2757190B2 (ja) * | 1988-09-28 | 1998-05-25 | テルモ株式会社 | 血小板保存用容器および血小板の保存方法 |
| US5167657A (en) * | 1988-11-14 | 1992-12-01 | Baxter International Inc. | Plastic composition with anti-hemolytic effect |
| US5100401A (en) * | 1988-11-14 | 1992-03-31 | Baxter International Inc. | Plastic composition with anti-hemolytic effect |
| US5026347A (en) * | 1988-11-14 | 1991-06-25 | Baxter International Inc. | Plastic composition with anti-hemolytic effect |
| JPH02177961A (ja) * | 1988-12-28 | 1990-07-11 | Kawasumi Lab Inc | 医療用具 |
| US4943287A (en) * | 1989-07-17 | 1990-07-24 | Miles Inc. | Red blood cell storage system |
| US5250044A (en) * | 1990-02-06 | 1993-10-05 | Du Pont Merck Pharmaceutical Company | Blood cryopreservation container |
| US5460625A (en) * | 1990-07-31 | 1995-10-24 | Baxter International Inc. | Cryogenic resistant coextruded tubing |
| JP2753772B2 (ja) * | 1991-04-08 | 1998-05-20 | 川澄化学工業 株式会社 | 医療用バッグ |
| US5683768A (en) * | 1994-12-21 | 1997-11-04 | Baxter International Inc. | Plastic formulations for platelet storage containers and the like |
| US6984526B2 (en) * | 1995-02-08 | 2006-01-10 | University Of South Florida | Spectrophotometric method for determining the viability of a sample containing platelets |
| US6146124A (en) | 1996-06-25 | 2000-11-14 | Thermogenesis Corp. | Freezing and thawing bag, mold, apparatus and method |
| US6808675B1 (en) | 1996-06-25 | 2004-10-26 | Thermogenesis Corp. | Freezing and thawing bag, mold, apparatus and method |
| US6213334B1 (en) | 1996-09-05 | 2001-04-10 | Baxter International Inc | Flexible, three-dimensional containers and methods for making them |
| US6361642B1 (en) | 1997-12-02 | 2002-03-26 | Baxter International Inc. | Heat and pressure-formed flexible containers |
| US6059968A (en) * | 1998-01-20 | 2000-05-09 | Baxter International Inc. | Systems for processing and storing placenta/umbilical cord blood |
| EP0995419B1 (en) * | 1998-10-21 | 2005-12-21 | Nipro Corporation | Method for producing a plastic vessel containing an albumin preparation |
| US20100087546A1 (en) * | 2005-04-20 | 2010-04-08 | Biogenic Innovations, Llc | Use of dimethyl sulfone (msm) to reduce homocysteine levels |
| WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
| CA2622204C (en) | 2005-09-12 | 2016-10-11 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same |
| WO2007033082A2 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Compositions comprising dimethyl sulfoxide (dmso) |
| US8480797B2 (en) * | 2005-09-12 | 2013-07-09 | Abela Pharmaceuticals, Inc. | Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors |
| US8449520B2 (en) * | 2007-03-19 | 2013-05-28 | HemCon Medical Technologies Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
| US7776022B2 (en) * | 2007-03-19 | 2010-08-17 | Hemcon Medical Technologies | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
| BRPI0921494A2 (pt) * | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração. |
| MX353712B (es) | 2009-10-30 | 2018-01-24 | Abela Pharmaceuticals Inc | Formulaciones de sulfoxido de dimetilo (dmso) y metilsulfonilmetano (msm) para tratar osteoartritis. |
| US9993389B2 (en) | 2011-09-19 | 2018-06-12 | Fenwal, Inc. | Red blood cell products and the storage of red blood cells in containers free of phthalate plasticizer |
| US9579253B2 (en) * | 2012-11-08 | 2017-02-28 | Grifols Worldwide Operations Limited | RFID tag and blood container/system with integrated RFID tag |
| KR102554521B1 (ko) | 2014-02-20 | 2023-07-11 | 프레제니우스 카비 도이치란트 게엠베하 | 적혈구 제품, 혈장 및 혈소판의 보관을 위한 비-ｄｅｈｐ 가소제를 갖는 의료용 컨테이너 및 시스템 구성요소 |
| JP6495677B2 (ja) * | 2015-02-12 | 2019-04-03 | リケンテクノス株式会社 | 医療用塩化ビニル系樹脂組成物 |
| CN113930028B (zh) * | 2021-10-20 | 2023-02-24 | 台湾塑胶工业股份有限公司 | 抗沾粘材料、含其的接触血液的医疗器材及其制造方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2275957A (en) * | 1938-02-11 | 1942-03-10 | Carbide & Carbon Chem Corp | Process for coating and laminating materials |
| GB584434A (en) * | 1944-01-24 | 1947-01-15 | Wingfoot Corp | Stabilization of vinyl resins |
| US2868745A (en) * | 1957-01-16 | 1959-01-13 | Harshaw Chem Corp | Vinyl chloride resin stabilized with three component stabilizer |
| BE563999A (enExample) * | 1957-01-18 | |||
| GB1460221A (en) * | 1974-01-21 | 1976-12-31 | British Petroleum Co | Stabilised vinyl chloride polymers |
| US3929700A (en) * | 1974-04-29 | 1975-12-30 | Hooker Chemicals Plastics Corp | Polyvinyl chloride composition |
| JPS5232900B2 (enExample) * | 1974-10-28 | 1977-08-24 | ||
| US4072790A (en) * | 1974-12-17 | 1978-02-07 | The Goodyear Tire & Rubber Company | Extrudable compounded polyvinyl chloride |
| DE2629620C2 (de) * | 1976-07-01 | 1986-01-09 | Robert Bosch Gmbh, 7000 Stuttgart | Fliehkraftdrehzahlregler für Einspritzbrennkraftmaschinen |
| DE2642509A1 (de) * | 1976-09-22 | 1978-03-23 | Neynaber Chemie Gmbh | Stabilisatorkombination fuer formmassen auf basis von polyvinylchlorid |
| US4346710A (en) * | 1978-06-16 | 1982-08-31 | Pennwalt Corporation | Article for storage and transport of biogenic fluids |
| JPS5560459A (en) * | 1978-10-26 | 1980-05-07 | Baxter Travenol Lab | Polymer that can coexist with blood and medical appliance manufactured from said polymer |
| GB2035093B (en) * | 1978-10-26 | 1983-01-12 | Baxter Travenol Lab | Medical articles made of blood compatible polymers |
| US4222379A (en) * | 1978-10-26 | 1980-09-16 | Baxter Travenol Laboratories, Inc. | Multiple blood bag having plasticizer-free portions and a high blood component survival rate |
| EP0011419A1 (en) * | 1978-11-09 | 1980-05-28 | TATE & LYLE PUBLIC LIMITED COMPANY | P.V.C. compositions for extrusion moulding |
| US4252705A (en) * | 1978-12-26 | 1981-02-24 | Argus Chemical Corporation | Resistance of polyvinyl chloride resins to discoloration during drying with N,N'-diphenyl urea |
| DE2914463A1 (de) * | 1979-04-10 | 1980-10-23 | Hoechst Ag | Medizinische geraete fuer parenterale fluessigkeiten |
| US4269743A (en) * | 1979-06-04 | 1981-05-26 | Dart Industries Inc. | Low toxicity vinyl halide stabilizer compositions |
| US4269744A (en) * | 1979-06-04 | 1981-05-26 | Dart Industries Inc. | Vinyl halide stabilizer compositions |
| US4280497A (en) * | 1979-10-09 | 1981-07-28 | Cutter Laboratories, Inc. | Container for platelet storage |
| EP0054221B1 (en) * | 1980-12-15 | 1986-04-09 | Miles Inc. | Multiple blood bag system made of plastic substantially free of blood extractible plasticizers |
| AU1947083A (en) * | 1982-09-27 | 1984-04-24 | Baxter Travenol Laboratories Inc. | Method and container for storing platelets |
-
1982
- 1982-09-27 US US06/424,679 patent/US4505708A/en not_active Expired - Lifetime
-
1983
- 1983-07-21 DE DE8383902616T patent/DE3381486D1/de not_active Expired - Lifetime
- 1983-07-21 WO PCT/US1983/001133 patent/WO1984001286A1/en not_active Ceased
- 1983-07-21 JP JP58502663A patent/JPS59501612A/ja active Granted
- 1983-07-21 EP EP83902616A patent/EP0120873B1/en not_active Expired - Lifetime
- 1983-07-21 AU AU18807/83A patent/AU573181B2/en not_active Ceased
- 1983-08-19 CA CA000434933A patent/CA1237075A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU1880783A (en) | 1984-04-24 |
| JPH0416183B2 (enExample) | 1992-03-23 |
| AU573181B2 (en) | 1988-06-02 |
| EP0120873A4 (en) | 1986-11-26 |
| EP0120873A1 (en) | 1984-10-10 |
| JPS59501612A (ja) | 1984-09-13 |
| EP0120873B1 (en) | 1990-04-25 |
| DE3381486D1 (de) | 1990-05-31 |
| US4505708A (en) | 1985-03-19 |
| WO1984001286A1 (en) | 1984-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1237075A (en) | Blood component storage container and method utilizing a polyvinyl chloride plastic formulation free or essentially free of leachable materials | |
| US4670013A (en) | Container for blood and blood components | |
| Pietersz et al. | Preparation of leukocyte-poor platelet concentrates from buffy coats | |
| US4657542A (en) | Medical instrument used for storage of blood | |
| CA1123791A (en) | Container for platelet storage | |
| Simmchen et al. | Progress in the removal of di-[2-ethylhexyl]-phthalate as plasticizer in blood bags | |
| KR102554521B1 (ko) | 적혈구 제품, 혈장 및 혈소판의 보관을 위한 비-ｄｅｈｐ 가소제를 갖는 의료용 컨테이너 및 시스템 구성요소 | |
| EP0537863B1 (en) | Use of a triglyceride compound as a hemolysis depressant | |
| EP0793414A2 (en) | Long-term blood component storage system and method | |
| US5248531A (en) | Hemolysis depressant and plasticizer | |
| Pietersz et al. | Preparation of Leukocyte‐Poor Platelet Concentrates from Buffy Coats: Lack of Effect on Storage of Different Plastics | |
| CA1285094C (en) | Pvc containers for blood and blood components | |
| Koerner | Platelet function of room temperature platelet concentrates stored in a new plastic material with high gas permeability | |
| Chawla et al. | Leaching of plasticizers from and surface characterization of PVC blood platelet bags | |
| JPS63125261A (ja) | 医療用具 | |
| JP2003171288A (ja) | 白血球除去血液製剤とその製造方法およびそのための製剤セット | |
| EP1635638A1 (en) | Processing of platelet-containing biological fluids | |
| Davey et al. | Characteristics of white cell‐reduced red cells stored in tri‐(2‐ethylhexyl) trimellitate plastic | |
| US20230022659A1 (en) | Compositions and methods for preserving or increasing platelet function | |
| Muylle et al. | Storage of saline-adenine-glucose-mannitol suspended red cells in diethylhexyl phtalate and butyryl-n-trihexyl-citrate plasticized polyvinyl chloride containers. An in vitro comparative study | |
| JPH0292358A (ja) | 血小板保存用容器および血小板の保存方法 | |
| CA3149000A1 (en) | Kits and methods for preparing plasma injectate biostimulator | |
| CA1306698C (en) | Hemolysis depressant, and medical resin composition, medical implement and blood preserving liquid using the hemolysis depressant | |
| JP2024500767A (ja) | 保存された赤血球の溶血を抑制するための使い捨て流体回路および容器 | |
| JPH04210061A (ja) | 血小板保存容器 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |